When evaluating pharmaceutical equipment configurations on Alibaba.com, understanding material specifications is fundamental to making informed procurement decisions. 304 stainless steel (also known as A2 stainless steel or EN 1.4301 in European standards) has become the de facto industry standard for general pharmaceutical manufacturing equipment, balancing performance, compliance, and cost considerations.
The chemical composition of 304 stainless steel is precisely defined by international standards. It contains 18-20% chromium and 8-10.5% nickel, with iron making up the balance and trace elements (carbon ≤0.08%, manganese ≤2%, silicon ≤1%) carefully controlled. This specific alloy composition creates a passive chromium oxide layer on the surface that provides excellent corrosion resistance in most pharmaceutical processing environments [1].
304 Stainless Steel Chemical Composition vs Alternative Grades
| Element | 304 Stainless Steel | 316 Stainless Steel | 201 Stainless Steel |
|---|---|---|---|
| Chromium (Cr) | 18-20% | 16.5-18.5% | 16-18% |
| Nickel (Ni) | 8-10.5% | 10-13% | 3.5-5.5% |
| Molybdenum (Mo) | 0% | 2-2.5% | 0% |
| Manganese (Mn) | ≤2% | ≤2% | 5.5-7.5% |
| Carbon (C) | ≤0.08% | ≤0.08% | ≤0.15% |
| Cost Index | 100 (baseline) | 130-150 | 60-80 |
For Southeast Asian manufacturers looking to sell on Alibaba.com, understanding these compositional differences is critical when positioning products for different buyer segments. The absence of molybdenum in 304 (compared to 316's 2-2.5%) is the key differentiator affecting chloride resistance—a factor that determines suitability for specific pharmaceutical applications.

